"India's Most Trusted Innovative Logistics & Supply Chain Company 2022" by Pharmaleaders.
We’re proud to announce that we have won the award "India's Most Trusted Innovative Logistics & Supply Chain Company 2022" by Pharmaleaders. This award reflects the dedication and commitment of our Indian team for providing innovative logistics supply chain and tailor-made solutions for our customers. The purpose of this award is to recognize the supply chain and logistics experts, organisations, and technologies that promote excellence in the Indian pharmaceutical supply chain.Learn more
The most innovative CEO in the Healthcare Logistics Industry
We are proud to announce that our CEO, Cedric Picaud, has won the ‘Most Innovative CEO in the Healthcare Logistics Industry” 2022 award from Business Worldwide Magazine.
"The winners edged forward with just that little bit extra, whether that was in terms of community engagement, or the ability to motivate staff.", Business Worldwide Magazine.Learn more
We are expanding our footprint to Spain, a dynamic and growing market for Cell & Gene and Clinical Research communities.
During the past few years, CRYOPDP has been actively acquiring companies with interesting new technologies, competencies, and with similar principles as ours to enhance our capacity to keep delivering live-saving goods around the world.
CRYOPDP has just acquired Polar Expres, a Clinical, Cell & Gene, and Biopharma logistics provider market leader fully dedicated to clinical trial logistics. Based in Spain, Polar Express has established customers, in the public and private sectors in Europe.Learn more
CRYOPDP opens a new Operational Excellence & Cold Chain Center in Warsaw
For years, we have proudly managed in Poland the safe and efficient delivery of pharma and healthcare products for our customers to ensure everyone has access to the treatments they need. And today, we took the future of our supply chain one step further by opening a brand new warehouse in Warsaw to match the life sciences' most critical demands.Learn more